Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

3.90
-1.4400-26.97%
Volume:212.16K
Turnover:863.00K
Market Cap:2.14M
PE:-0.04
High:4.90
Open:4.90
Low:3.74
Close:5.34
52wk High:179.19
52wk Low:3.74
Shares:547.78K
Float Shares:547.42K
Volume Ratio:5.28
T/O Rate:38.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4151
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.43
PE(LYR):-0.01

Loading ...

Artelo Biosciences Reports Positive Preclinical Data for Art26.12 in Spinal Cord Injury Neuropathic Pain Model

Reuters
·
Jul 01

Artelo Biosciences Announces New Data Supporting Art26.12 as a Potential First-in-class Therapy for Chronic Pain Associated with Spinal Cord Injury

THOMSON REUTERS
·
Jul 01

Artelo Biosciences Says Phase 1 FABP5 Inhibitor Art26.12 Study Shows Linoleic Acid Signaling Link Across Disease Models

Reuters
·
Jun 30

Bitcoin Mining Firm Ionic Digital Files for Direct Listing on Nasdaq

Stock News
·
Jun 30

Artelo Biosciences Says Phase 1 Study Shows FABP5 Inhibitor Art26.12 is Well Tolerated, with Linear Pharmacokinetics

Reuters
·
Jun 29

Bank of America Issues Warning: Nasdaq Reaches "Bubble Threshold" Driven by Semiconductors

Deep News
·
Jun 25

U.S. Markets Open Mixed as Focus Turns to SpaceX Nasdaq Debut

Deep News
·
Jun 12

Artelo Biosciences reports favorable human metabolite profile for ART26.12 in completed SAD trial

Reuters
·
Jun 10

Artelo Biosciences Launches Flexible At-The-Market Offering

TIPRANKS
·
May 28

Top Premarket Decliners

MT Newswires Live
·
May 27

Artelo Biosciences announces annual shareholder meeting

Reuters
·
May 27

Artelo Biosciences Inc - to Offer up to $6.53 Mln in Common Stock via H.c. Wainwright - SEC Filing

THOMSON REUTERS
·
May 27

Top Premarket Gainers

MT Newswires Live
·
May 26

Wall Street Expands Crypto Asset Integration as SEC Approves Nasdaq's Bitcoin Options Product

Stock News
·
May 23

Global Financial Headlines: Pershing Square Takes Position in Microsoft, Mehlan Steps Down from Fed, SpaceX Picks Nasdaq for IPO

Deep News
·
May 16

Artelo Biosciences Ends ATM Offering, Shifts Financing Strategy

TIPRANKS
·
May 16

Artelo Biosciences Inc - to Terminate at-the-Market Offering Agreement Effective May 18, 2026 - SEC Filing

THOMSON REUTERS
·
May 16

Dollar's Resurgence Weighs on Gold as Tech Stocks Face Potential Pressure

Deep News
·
May 15

Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate

Benzinga Earnings
·
May 15

Artelo Biosciences Q1 FY26 net loss widens 24.7% to USD 2.96 million

Reuters
·
May 15